EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice

Lenny Moise, Matt Ardito, Joe Desrosiers, Jill Schriewer, Mark Buller, Sharon E. Frey, Stephen H. Gregory, Steven F. Moss, Jinhee Lee, Hardy Kornfeld, Bill Martin, Anne S. De Groot

Procedia in Vaccinology · 2009

DOI: 10.1016/j.provac.2009.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Procedia in Vaccinology, 2009. Verfasst von Lenny Moise und 11 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While whole killed, whole protein, or live attenuated vaccines were the standard bearers for protective vaccines in the last century, there are concerns about their safety. New vaccine design techniques are contributing to an emphasis on vaccines developed using the minimum essential subset of T- and B-cell epitopes that comprise the “immunome.” We have used bioinformatics sequence analysis tools, epitope-mapping tools, microarrays and high-throughput immunology assays to identify the minimal essential vaccine components for smallpox, tularemia, Helicobacter pylori and tuberculosis vaccines. As will be described in this review, this approach has resulted in the development of four immunome-derived epitope-driven vaccines (ID-EDV); three of these proved protective against viral or bacterial challenge. Protective efficacies of 100% (vaccinia), 90% (H. pylori), and 57% (tularemia) were achieved in HLA-transgenic (humanized) mouse models and the p27 knockout mouse (for H. pylori). Such immunome-derived vaccines have a significant advantage over conventional vaccines; the careful selection of the components should diminish undesired side effects such as those observed with whole pathogen and protein subunit vaccines. Here we summarize data showing prototype ID-ED vaccine protection against lethal challenge with vaccinia, tularemia, and H. pylori in a model of infection. The tools that made these successes possible are described and the anticipated clinical development of ID-ED vaccines is discussed.

Zitieren

APA

Moise, L., Ardito, M., Desrosiers, J., Schriewer, J., Buller, M., Frey, S. E., Gregory, S. H., Moss, S. F., Lee, J., Kornfeld, H., Martin, B., & Groot, A. S. D. (2009). Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice. Procedia in Vaccinology. https://doi.org/10.1016/j.provac.2009.07.004

Vancouver

Moise L, Ardito M, Desrosiers J, Schriewer J, Buller M, Frey SE, et al. Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice. Procedia in Vaccinology. 2009. doi:10.1016/j.provac.2009.07.004

BibTeX
@article{Moise2009,
  author = {Moise, Lenny and Ardito, Matt and Desrosiers, Joe and Schriewer, Jill and Buller, Mark and Frey, Sharon E. and Gregory, Stephen H. and Moss, Steven F. and Lee, Jinhee and Kornfeld, Hardy and Martin, Bill and Groot, Anne S. De},
  title = {Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice},
  journal = {Procedia in Vaccinology},
  year = {2009},
  doi = {10.1016/j.provac.2009.07.004}
}
Kostenlos starten →